The susceptibility of pathogenic free-living amebae to chemotherapeutic agents : a thesis presented in partial fulfilment of the requirements for the degree of Master of Science in Microbiology at Massey University by Donald, Jennifer Jane
Copyright is owned by the Author of the thesis.  Permission is given for 
a copy to be downloaded by an individual for the purpose of research and 
private study only.  The thesis may not be reproduced elsewhere without 
the permission of the Author. 
 
THE SUSCEPTIBILITY OF PATHOGENIC 
FREE-LIVING AHEBAE TO 
CHEMOTHERAPEUTIC AGENTS 
A thesis presented in partial fulfilment of the 
requirements for the degree of 
Master of Science in Microbiology at 
Massey University, Palmerston North, 
New Zealand 
Jennifer Jane Donald 
1979 
ii 
ABSTRACT 
======== 
The treatment of inf ect i ons caus ed by pathogenic fr ee- l iving 
amebae (PFLA) has, u n ti l o nly r ecent l y, b een far fr o m succe s s ful . Th e 
co n t inued scr een i n g of c hemot h e r apeu tic agent s agai n st amebae of the 
g e nera Naeg l er i a a nd Acan thamoeba i s the refor e of the ut1no st i mpor t a nc e. 
Se v e n c h emo t h erapeuti c agents, amphoter i ci n B, r i fampici n , 
tetracy c l i ne, po l y my xin B sulphate, 5 - fluo r o cytos i n e , miconazo l e a nd 
R41 ,400 were screen e d f or a ct i v ity agai ns t a non -pat hoge nic and 
p a t hog enic species of Naeg l e ri a a nd a non - pathogen i c a nd pathoge n ic 
species of Acan t hamoeb a in axenic c ul t ure. For th e Naeg l e ria spp . 
ampho t e ri c in B, mi co n a zole and R41, 400 were foun d to b e acti ve . Acan -
t h amoebae spp. were foun d to b e susceptib l e only t o 5 -fluo r ocytos ine 
and R41 ,400 . 
The poss ibl e u se of c ombinat i ons of drugs agai n s t the amebae 
was al so i nve s t igat e d in axenic cu lture . Fo r Naeg leria fow l e r i ( MsT) 
a mphoter i c i n B wit h e ithe r tetra cycli n e or r ifampi c i n showed a s y n er -
g i st i c e f fect . Polymyxin B sulphate and 5 - fluo rocy to s i n e showed 
syn erg i s tic ac t ivity a gainst Ac a nthamo eba cu l ber t s on i ( A-1 ) but wh e n 
po l ymyx:in B wa s comb i ned wi t h tetracyc line or ri famp i c in no s i g n if i cant 
additive e ff ec t wa s s een. 
Aft e r axen i c culture testing the suscept i b i lity of the path o-
gen ic s pec i e s,~. fowl e ri ( MsT) a nd A. c ul ber tson i (A- 1) , to the agen ts 
wh ich s howed ac tiv ity,was i nves t i gated i n a Ve r o ce ll c ul t u re s ystem . 
Fo r N. f ow l eri (MsT) t h e resu l t s of axeni c testi n g were con firmed with 
a mpho t eri ci n B, mic onazo l e a nd R41, 400 p r o t ecti n g t h e monol ayer f r om 
the d e s tru c tive e ff e ct s of t h e amebae . 5-Fluorocy tosine inh ibit e d th e 
formation of cy topa th i c e f fect (CPE) when the cell cultu r es we r e 
inoc ulated with A. culbe r t soni (A-1) but viable a mebae were still 
pre sent. R41,400 had no effect on A. culbe rtson i (A-1) at concentra-
tions at or above those whi ch were cy t otoxic to the Ve r o cells. 
The use of combinations of drugs was also investigated i n Vero 
cell culture. Amphotericin Band rifampicin showed an antagonistic 
rather than a synergistic effect when used against~- fowleri (MsT) 
in cell culture but amphote r icin B and tetracyc~ine showed synergistic 
activity. 
For A. culbertsoni (A-1) the synergistic activity of polymyx in B 
and 5-fluorocytosine was confirmed. The lack of an addi tiv e e ff e c t 
between polymyxin Band either tetracycline or rifampicin was also 
shown in cell culture. 
The new imidazole derivative R41,400, which showed promise 
against N. fowleri (MsT) in i n vitro tests was then tested in the 
in vivo situation. Mice experimenta lly infected with B- fowl eri 
(MsT) were treated once or twice daily intraperitoneally with 
different doses of R41,400 . At the higher dosage l evels tested the 
drug app eared to have a deieterious effect , the average time for 
death being less than that for the controls . 
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CHAPTER ONE : IN TRODUCTION 
Th e histo ry of pathogen i c fr ee - l i ving amebae (P FLA) o f t h e ge n e ra 
Acan t h amoe ba 2nd Naeg l e ri a has be e n ex tensive l y r evi ewe d e ls e wh e re 
(Cu l b e rtson , 1971; Du ma e t .§1 . , 1971; Ch a n g , 19 7 1 , 19 74a ; Ca r te r, 19 7 2 ; 
Cu r son s , 1974 ; Cur sons & Brown, 197 6 ). 
Th e commones t d iseas e c au s e d by P FLA i s k nown as P r imar y Ameb ic 
Me n i n go - encepha l i t i s (PAM ) and i n a n ext e ns ive wor ldwi d e survey , 
Will aer t ( 19 74 ) tabu l a t e d 84 cases f rom a ll cont i ne n t s wi th th e ex -
c e p t i o n of Antarc tica . S i nce the n a t l ea s t te,1 additiona l case s have 
b e e n repor t e d. 
Pri or to 19 68 , mo st case s we re attribu t e d t o Acanth amo e ba spp .. 
Th is is pro bab l y a r e f l ection of the p i o n eering work o f Culbertson 
e t a l. (1 958 , 1959 , 1965 ) wh om , whi l st working on the production of 
po lio vacci n e , f ound a n ameba which co ntam i nat e d the c u l tures o f monkey 
kidney ce ll s . When the cul t ur e s we re ino cul ated intra c e r e bra l ly i n to 
mice a nd primates, a n ec r o t izing, h emor rhagic meni ngo - e nceph a lit i s 
wa s produced that k ill ed t h e a n ima ls in f our t o s even days . Th e res -
po ns ibl e ameba wa s ide n ti f ied as a n Acanthamoeba a nd they p r e d i cte d , 
o n the b a sis of this f i nd i ng, that this ameba c ou ld b e capabl e of 
produc ing di sease in huma ns. Thi s ameba wa s previ ous l y co nsid e red to 
b e a harml e ss, fr e e-l i ving a meba. 
However, in 19 68, Bu t t e t ~1-, Ca rt e r a nd Culbertson e t al., 
showed that the i n c r imi nating spe ci e s of most r e po rte d human c ases 
belonged to the r e lat e d g enus Naegl e ria. In 1970, on the basis of 
mo rphological, cultural and pathogenicity diff e r ences, Carter n a med 
the pathogenic speci e s Nae gl eria fowl e ri d i stinguishing it from the 
non-pathogenic Naegler i a gruberi. 
The disease caused by PFLA can be divided into two types: 
i) a swimming - associated acute meningo-encephalitis (Primary Amebic 
Meningo- encephalitis (PAM) - Martinez et al.(1977) caused by 
N. fowleri. 
and ii) a non-swimming - associated chronic meningo-encephalitis 
(Amebic Meningo-encephalitis (AM) - being regarded as a second-
ary invasion of the central nervous system (CNS) having spread 
from other foci of infection (Martinez et al., 1977)) caused by 
a variety of pathogenic Acanthamoebae, notably Acanthamoeba 
culbertsoni, Acanthamoeba castellanii and Acanthamoeba polyphaga 
(Chang, 1974a). 
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Subsequently, Acanthamoeba spp. have also b een indicated in a number 
of chronic illnesse s such as respiratory infections (Martinez et~-, 
1975 ), corneal ulceration of the eye resulting i n bl i ndness (Nagington 
et~-, 1974; Visvesvara et al., 1975) and togethe r with Naegleria spp. 
in humidifier f ever (M.R.C. Symposium, 1977). 
Henceforth in the text the nomenclature of Martinez et al . C1977), 
PAM for Naegleria inf ections and AM for Acanthamoeba meningo-encephalitis, 
will be adopted. 
The controversy regarding the classification of PFLA (Cursons & 
Brown, 1976) appears to be settled with the majority of authors 
preferring Chang's (1971) classification scheme. The identification 
of isolates involves the exploitation of specific cytological, morph-
ological, physiological, immunological, growth and pathogenicity 
characteristics in an ordered sequence readily usable by hospital and 
public health laboratory staff (Cursons & Brown, 1976). 
1.2 Occurence and Distribution 
The summary of recorded isolations from a wide variety of 
environme ntal sources provided by Cursons (1978) emphasizes the truly 
ubiquitous distribution of PFLA. The ability of PFLA to form resistant 
cysts undoubtedly enables them not only to withstand unfavourable 
conditions, e.g., the isolation of pathogenic Acanthamoebae from 2°c 
(Brown & Cursons, 1977), but also to take advantage of the intermittent 
occurrence of favourable conditions. 
The distribution of the pathogenic species in relation to 
non-pathogenic ones is still unknown (Cursons, 1978). In general, 
non~pathogenic species are more prevalent at ambient temperatures in 
temperate zones. The repeated isolations of PFLA from water above 
ambient temperature, i.e.,~30°C (De Jonckheere et al., 1977j 
De Jonckheere & Van De Voorde, 1977a; Stevens et al., 1977; Wellings 
et al., 1977; Cursons et al., 1978b), combined with their higher 
optimum temperature of growth (Griffin, 1972) suggests that pathogenic 
amebae are environmentally selected over non-pathogenic amebae in 
waters above ambient t emperature. The source of pathogenic amebae in 
these waters is unknown but as Cursons et al. 0978b) and Wellings 
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et al. (1977) have succeeded in isolating PFLA from soil it is possible 
that soil acts as a reservoir of pathogens and contamination occurs 
via run-off after rain (Cursons, 1978). 
1.3. Pathogenicity 
The invasion of organs and tissues by PFLA is now well document ed 
(Culbertson et al., 1959 , 1968, 1972; Cart er, 1968, 1970, 1972; Call i -
cott et _tl., 1968 ; Chang, 1971, 1974a & b, 1976; Culbertson, 1971; 
Martinez et~ - , 1973, 1975 , 1977; Vi svesvara & Balamuth, 1975; Wong 
et E-l•, 1975a & b; Hoffman et al., 1978). It has been es tabl i shed 
experimentally that the portal of entry into the CNS in N. fowleri 
infection is via d i sruption of the olfactory mucosa, penetration of the 
organisms into the submucosal nervous pl exus, probably by phagocytosis 
of the amebas by the sustentacular cells of the olfactory neuroepithel-
ium a nd passage through the cribiform plate to the subara chnoid space 
( Martinez et al., 1973). 
Ho\vever, in cases of Acanthamoeba meningo-encephalitis the 
involvement of the CNS appears to be a secondary phenomenon representi ng 
metastatic spread from a primary focus in the skin, genitourinary or 
respiratory tract (Martinez et al ., 1977). Cutaneous ulceration as a 
possible point of entrance with hematogenous spread to the CNS was 
reported by Bhagwandeen et al. (1975) and Martinez et al. (1977) 
report involvement of the genitourinary tract. Lower respiratory tract 
infection in experimental animals have been reported (Martinez et al., 
1975). 
AM due to Acanthamoeba spp. appears to be an opportunistic 
infection of the CNS. AM occurs in patients who are chronically ill, 
debilitated or those whose cell-mediated immune responses have been 
impaired as a result of either underlying systemic disease or its 
treatment by immunosuppresive methods (Kernohan et al., 1960; Jager & 
Stamm, 1972; Robert & Rorke, 1973; Sotelo-Avila et al., 1974; Bhagwan-
deen et al., 1975). 
Acanthamoeba infections of sites with reduced accessibility to 
the immune system e.g., the eye also demonstrate the opportunistic 
nature of these infections. Isolates from the cases reported by 
Nagington et al. (1974) were shown by Visvesvara et al. (1975) to be 
of low virul ence and infection resulted after damage to the cornea . 
Once invasion of the brain has been established i 1, PAM and AM, 
destruction of surrounding brain tissue is thought to be brought about 
by a combi nati on of phagocytosis and pinocytosis of host tissue by 
N. fowleri and solely by pinocytosis i n the case of A. culbertsoni 
(Vi svesvara & Callaway , 1974; Mai tra et ~ - , 1974, 1976) . 
The examination of sections from brains i nfected with either 
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N. fowleri or A. culbertsoni revea ls areas of extensive demye lination 
leaving the trophozoites surrounded by a clear halo (Martinez et a l., 
1975; Chang, 1976 ; Maitra e t a l., 1976 ). Many authors have speculated 
on the possibil ity that enzymes secreted by the amebae are responsible 
for thi s. Exper i ment s have shown that both cytotoxi c enzymes a nd phos-
pholipases are produced by PFLA (Elson et al ., 1970; Chang, 1971, 1974a, 
1976; Hax et al., 1974; Visvesvara & Callaway, 1974; Vi c toria & Korn , 
1975; Visvesvara & Ballamu t h, 1975; Cursons & Brown, 1976, 1978; Cursons 
e t .§:.1.•, 1978c ; Maitra et al . , 1976 ). The l eve l of production of such 
cytopathic enzymes may explai n the diffe r ences in virulence reported 
amongst Acanthamoeba and N- fowl eri isol a tes (Culber tson, 1971; De 
J onckheere & Van De Voorde , 19 77b). 
l . 4. 1~!:!!}.!!Y 
--------
The lm·J incidence of PAM and AM in the human population ha s 
puzzled many authors in view of the ease a nd frequ ency of isolation of 
virulent PFLA from the environment (Anderson & J amieson, 1972; Cursons 
et al., 1976b, 1977; John et al., 1977; Wellings et al., 1977; Haggerty 
& John, 1978). This has led to speculation on the existence of host 
related susceptibility factors and the demonstration of specific 
antibodies to free-living amebae in human sera has been reported (Chang 
& Owens, 1964; Edwards et al., 1976; Cursons et al., 1977; M.R.C. 
Symposium, 1977). 
Observations that previous exposure of mice to live N• gruberi 
significantly protected them against a subsequent lethal challenge with 
~- fowleri (John et al., 1977) supports the idea that unwitting ex-
posure to the ubiquitous~ - gruberi may immunize against~- fowleri. A 
similar immunization may also occur with Acanthamoeba . Cell-mediated 
immunity (CMI) also appears to play an important part in protection 
against PFLA (Diffley et al., 1976; Cursons et al., 1977). 
1 .5. !2i§g!:!Q§i§ 
---------
Successful treatment of this rapidly progressive disease is 
whol l y dependent on prompt and definitive diagnosis . The survival of 
a nine year old female in Torrance, California (Seidel et a l. , pers . 
comm., 1978) and a fourteen year old male in Australia (Anderson & 
Jamieson, 1972) i s attributed to early diagnosis and prompt treatment . 
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A Naegleria brain infection should be suspected when th ere is a 
history of swimming about seven day s prior to the abrupt onset of fever, 
headache, sore - throa t, nausea and vomiting ( Carter, 1972; Chang, 1974a) . 
The most important laboratory procedure for the diagnos i s of PAM is the 
microsc opic examination of cerebra-spinal fluid (CSF) . Overall, the 
CSF is indistinguishable from t hat obtained from pat i ents with bacterial 
meningitis and diagnosi s re l ies upon amebae being seen i n t he fl ui d a nd 
the culture of these for complete diagnosis . Species identification 
can th en be achieved by the method outlined by Cursons & Brown ( 1976) . 
In post- mortem diagnosis, a degree of encephaliti s is invar iably 
present . The brain shows swel l ing and redness with the purulent exudat~ 
more extensive on the ventral surface of the cerebrum or cerebe llum and 
over t he bra in stem ( Car ter , 197 2) , The gr ey mat t er of t he cer ebra l 
h emispheres a nd cerebe llum sho ws var iabl e si zed l es i ons wh ich tend to 
be hemo rrhagic and qui t e sof t wh en they are l arge (Cul ber t son, 1971 ) . 
The existence of r edness a nd destruction of t he ol f ac t or y nerve occur s 
only i n PAM and could s e r ve to distingui sh i t from bac t er i a l mening i tis 
(Ca r ter, 19 72 ). 
Th e immunof luorescent an tibody (IFAB) technique applied to 
h isto logic ·bra i n s ection s taken pos t- mor tem , i s a valuabl e t ool in 
i dent i fi cation of amebae i n brains of pat i ents who d ied from men i ngo-
e ncephal i tis. Anti sera can be pr oduc ed in rabbits and can be made 
spec ies-spec i fic by sui tabl e abso r pt ion. In additi on t o their value in 
clinical diagnosis IFAB provide rapid screening methods for the detect-
ion of PFLA in swi mmi ng pool, tap and other domest i c and recreational 
water supplies. 
Immunoperoxi dase methods have been used by Culbertson (1975) and 
Cursons et al. (1976) to demonstrate both Naegleria and Acanthamoeba 
in the brain sections of patients who died from PAM and AM respectively. 
This method may be shown in the future to be more valuable than the 
immunofluorescent technique. It has certain advantages over IFAB, e.g., 
permanent preparations can be made, no specialized equipment is 
necessary and cl ear , definitive staining of the tis sue elements 
r esults (Culbertson, 1975). 
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Acanthamoeba brain infections are difficult to diagnose even 
in advanced cases due to lack of specific symptoms and signs and the 
absence of amebae in the CSF (Chang, 1974a) . Nasa l and throat swabs 
may provide more information. 
Post - mo r tem diagnosis relies on the presence of c onf i ned, 
superficial l esions in the grey mat ter with a minimum inflammatory 
r eaction, and the find i ng of double-walled wrinkled cysts i n appar -
ent l y normal tissue borderi ng the lesion (Chang, 1974a) . In all the 
reported cases, except that reported by Bhagwandeen et~ - (1 97 5) , 
there was l ack of evidence of the i nvolvement of the olfactory bu l b 
and the absence of inflammatory reactions i n the surrounding grey a nd 
white matter. These observations may help in dist i ngu i shing between 
PAM and AM . 
Positive d iagnosis was possible in the cases of eye infections 
reported by Nagington e t al. (1 974) and J on e s e t a l. (1975) by iso-
lation , and subs equent identification of Acanthamoebae spp . taken 
from corneal scrapings . 
1. 6 . Control Measure s 
----------------
The necess ity for an effective disinfectant can be judged by the 
increasing number of i so lations of free-living amebae from potable and 
tr eated and untreated recreational water s (Cerva, 1971 a ; Chang, 1971; 
Anderson & J amieson, 1972 ; Cerva & Huldt, 1974; Ma let et al., 1976; 
Lyons & Kapur, 1977). The majority of amebae isolated i n these studies 
belonged to the genus Acanthamoeba indicating its greater r e s i stance to 
chlorine than Naegleria spp .. 
In reviewing sixteen fatal cases of PAM from an indoor chlorinated 
swimming pool Cerva (1971a) stated that, " it appears that the constant 
presence of numerous populations of a mebae of the limax group cannot be 
prevented even under the strictest observations of all routine safety 
measures applied to potable waters." However, Lyons & Kapur (1977) in 
a survey of 30 halogenated public swimming pools concluded that the low 
amebic densities (~ 1.1- 1 ) in the majority of the pools illustrated that 
these organisms could be adequately controlled by proper pool maintain-
ence. The possession of resistant cysts, however, constantly compli-
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cates the disinfection process. 
In a s tudy of alternative disinfectants, Cursons et~- (1978b) 
found that deciquam 222, chlorine, chlorine dioxide and ozone all 
possessed potential disinfecting properties for PFLA , but at higher 
leve ls than those for disinfecting bacteria . Of the four disinfectants 
exami ned, deciquam 222 proved to be the most ef f ective amebicide 
followed by chlor ine, chlorine d ioxide and ozone . The final choice of 
a particular di sinfec t ant must however, remain ti ed to the physical 
and chemica l properties of the water to be disinf ected. 
1.7. PAM Cases and Their Treatment 
In 1974, Willaert provided an extensive worldwi de survey of 
cases of PAM . Since then at l east ten additi onal cases have been 
reported (Table I). Conceivably, the actual number of cases may be 
hi gher since the symptoms of PAM parallel those of aseptic meningi t is . 
Retrospective studies have disclos ed a possible case dating back to 
1909 (Symrne r s, 1969 ) and fluor esc~nt antibody staining has conf irmed 
that t h e 1948 case reported by Derrick , originally thought to be due 
to Iodamoeba butschl ii was in fact caused by~- f owleri (McMillan, 
1977). The reid ent i fication of the etiological agents of the 19 68 
cases of PAM in New Zealand as N. fowle r i (Cursons & Brown, 1975 ; 
Cursons et al., 1976a ) has dismissed the notion of slime moulds being 
involved in the etiology of PAM (Mandal et al., 1970). 
The r esu lts of treatment of PAM have been far from encouraging. 
Willaert's summary (1974) provides information on ten possible 
survivors of PAM and the California n case of Seide l et al. (pers. 
comm., 1978) makes the world total eleven survivors (Table II). Such 
a result is hardly surprising in the earlier cases, where the amebic 
nature of the disease had not been suspected, and treatment consisted 
only of antibacterial agents such as sulpha-drugs, penicillin, strep-
tomycin, tetracyclines and chloromphenicol (Fowler & Carter, 1965; 
Butt et al., 1968; Cerva & Novak, 1968; Dos Santos, 1970; Van den 
Driessche et al., 1973). However, even in later cases where the anti-
protozoal drugs emetine, chloroquine and metronidazole were often 
used, the course of the disease was not affected in the slightest 
(Carter, 1968, 1970, 1972; Duma et al., 1971), except in the unproved 
case of Grundy and Blowers (1970) in which survival was attributed 
to chloroquine. In this case, amebae, believed to be Naegleria, were 
NUMBER CAUSATIVE 
COUNTRY YEAR OF CASES ORGANISM DIAGNOSIS TREATMENT OUTCOME REFERENCE 
1974 1 N. fowleri (MsT) isolation Penicillin di ed Cursons et ~-, 1976b 
from CSF Ampicillin NEW Amphotericin B ZEALAND 
1978 1 ~- fowleri (MsM) isolation Amphotericin B died Cursons e t al., pers. 
from CSF comm., 1978 
1974 1 N. fowleri (Lovell) isolation Unknown died De Jonckheere, 1977 
from CSF 
1974 1 Acanthamoeba sp. IFAB Steroids died Martinez et ~-, 1977 
U.S.A. Penicillin 
1975 1 Acanthamoeba sp. IFAB Unknown died Hoffman et al., 1978 
post-mortem 
1978 1 Naegleria sp. isolation Amphotericin B survived Seidel et al ., pers, 
from CSF Miconazole comm ., 1978 
Rifampi n 
VENEZUELA 1 !:. . culbertsoni IFAB Steroids died Marti nez et al., 1977 
1 A. castellanii IFAB Steroids died Martinez et al ., 1977 PERU - Antibiotics 
1972 1 Acanthamoeba sp. post - mor tem Antibiotics died Bhagwandeen et al., ZAMBIA Amphoter icin B 1975 
1958 1 Acanthamoeba sp. post- mor t em Penicillin d ied Ri ngst ed et ~., 1975 
KOREA Strep tomyci n 
Chloramphenicol 
Table I: Cases of Primary Amebic Meningo- enc ephali t is Reported After 1974 (modified from Cursons, 1978) 
C'. 
NUMBER CAUSATIVE 
COUNTRY YEAR OF CASES ORGANISM TREATMENT REFERENCE 
1968 1 Naegleria Metronidazole - Grundy & Blowers, 
UGANDA Emetine - Penicillin 1970 
Chloroquine. 
1967 1 A. astronyxis Ampici llin Callicott et al., 
Penicilli n - G 1968 
U.S.A. 1978 1 Naegleria Amphotericin B Seidel~ ..el_., pers. 
Miconazole comm. 1978 
Rifampin 
1970 2 Naegleria Streptomycin Pan & Ghosh, 1971 
Isonicoteinhydrosine 
INDIA Sulphadexanathosone Amphoteri cin B 
1973 3 N. fowleri Unk:nown S . R. Das, pers. comm . 
to Willaert(l974) 
1969 2 Naegleria Antibiotics Apley et al., 1970 
ENGLAND Sulphadiazine 
Amphotericin B 
1971 1 N. fowleri Amphotericin B Anderson & Jamieson, 
AUSTRALIA - Sulphadiazine 1972 
Table II: Probable and Definite Survivors of Primary Arnebic Meningo-encephalitis 
\0 
s een in the CSF and survived f or awhi l e i n cu l ture but were not 
po s it ively i d enti f ied, The patient a l so presented atypical c l inica l 
features . Treatment consisted of metronidazo l e , emeti ne, penicillin , 
sulphane and chl or oquine . 
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The ineffectiveness of antibacterial agents against pathogenic 
Naegl eria has been confirmed in vitro by Carter (1969) and Mandal et 
§1_ . (1970) . Of the antiprotozoal agents, emetine HCl is effective 
agains t !:i , fowleri i n vitro . Carter (19 69 ) r eported a minimum immobil-
izing l eve l of 12 . 5 ;-< g . cm- 3 a nd Krishna Prasad (1972) and Das (1975) 
r eport minimum amebicida l concentrations of 16 and 15.l" g.cm- 3 respect -
ive l y , but, it does not protec t anima l s from the dis ease (Culbertson 
et al., 1968) probably because it is unable to pass the blood-brain 
barrier (Parmer & Cottril l, 1949) . The ineffectiveness of chloroquine 
a nd metroni dazo l e has a l so been co nf i r med by i n vit r o t e st s and a nima l 
protection studies (Carter, 1969; Manda l et ~-, 1970; Duma et a l. , 
1971) . 
The only drug to appear promisi ng i n the ear l y 1970' s wa s t h e 
a nti f unga l agen t amphotericin Band as can be seen from Tabl e II i t was 
used i n the treatment of all survivors (except the unproved case of 
Grundy & Bl owers, 1970 a nd Callicot t e t .§.1_. , 1968) . Amphoteric in B is 
a po l yene a nt ibio tic a nd ha s been shown to be h ighly amebici da l to 
pathogen ic Naeg l e ri a i n v i tro (Ca r ter, 1969; Handa l e t al., 1970; Duma 
e t al. , 1971 ; Schuster & Rechthand, 1975 ; Visvesvara & Balamu t h , 1975; 
Duma & Fi nl ey , 1976 ; De Jonckheer e & Van De Voorde , 1977; Dona ld e t al., 
1979 ) and t o protect mi ce fr om the d i s ease ( Culber tson e t a l., 19 68 ; 
Ca rt er, 1969; Das, 1971). 
In 1969 , Carte r suggested t ha t a mphote ricin B be tri ed i n the 
t reatment of PAM by s i multaneous intravenous (IV) and intraventricular 
(IVent) administration; the doses r ecommended were - 0.25 mg.kg-l IV 
and 1.0 mg into the cerebral ve nt r i cles in the first 24 hours . Carter 
(1972) also suggested sulphadiazine should always be used as well as 
amphotericin Bin case the amebae should occasionally prove to be 
Acanthamoebae . These amebae have been shown to be resistant to both 
drugs in vitro (Casemore, 1970; Chang, 1971; Visve svara & Balamuth, 
1975; Duma & Finley, 1976; Nagington & Richards, 1976; Donald et al . , 
1979), but there is good evidence that they are affected by sulpha-
diazi ne in vivo (Culbertson et al., 1965). 
Subsequently, such treatment was tr i ed on two patients in the 
U.S.A. (Duma et al., 1971) who were in the early stages of the disease 
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and should ha ve r e spond e d . I n th e f i rst of the s e , (Pati e nt 3, Duma 
e t al ., 1971) a ri ght v entr i cu l ar tap was performed a nd aft e r r emova l 
of flu i d (containing many motile a mebae) 1. 5 mg of amphot e r i ci n B 
di ssolved i n 5 cm3 of 5% dextrose inj ect i on solut i on (D5W) was s l owly 
i n jec t ed into the vent ri c l e . 10 mg of a mphot e ricin Band 10 mg 
d exame thason e we r e administ e r ed IV . A nasoga stric tube was inserted, 
t h r ough wh ich 400 mg o f metronidazol e was gi ven f our t imes dai ly . Th e 
pati e nt a lso r e c e ived chloro quine ba se, 200 mg an d dexamethason e , 4 mg, 
intramuscu l a rl y ( IM ) every six ho u r s. Sixteen hours after a dmission 
the ventricu l a r tap was r epeated a nd 1. 5 mg o f amphotericin B was agai n 
i nj ected into the v entric l e . Sev enty - two hours after admi s s i o n h e 
b ecame s h ock- l i k e , res p i rat i ons c eas e d and h e died. 
Th e second cas e (Patien t 4 , Duma et a l. , 1971 ) receiv ed , within 
3 two hours o f admission , 1.5 mg amphoteri c i n B d i l uted in 5 c m D5W 
i nt rac i sterna lly (IC i st) and 10 mg a mphoter i c in B a nd 5 0 mg hy drocort -
ison e IV over the next f our hou r s . In a ddition, chloro qui n e su l pha t e , 
200 mg I M; me t r on i dazo l e , 50 0 mg by nas o gastr i c tube ev e r y s ix hours; 
and d i phe ny l hydanto i n (D i lant i n), 100 mg I M every eigh t hours, wa s 
g iv e n . E~ghteen h ours a ft e r admi ss io n, the pat ient aga in r eceived 
1. 5 mg amphoter i cin B ICi s t and the IV a mphoter i cin B i n c r e as e d to 
20 mg . The pati ent d ied 66 hours a f ter admi ssion . 
Car t er ( 1972) r e ports simi lar fi nd i n gs t o Duma et al . ( 197 1 ) 
in two pa t ients (7th a nd 9th , Tabl e III , Cart e r, 19 7 2) who h ad b een 
treated in t h e same way . 
Ap l ey e t a l.(1 9 70) d e scr i be d t h ree c ases of PAM in Grea t Br itain, 
t wo of wh i ch wer e d iagno s e d presumptive l y becau se of association with 
t h e f ata l proven ca s e . They had t h e same early symptoms but nei ther 
actua lly develo ped convincing s i gns o f men i ngitis. Naegl eria was 
cultured from the CSF o f the child who di e d and from one o f the others 
but the amebae prove d to be~- g r uberi. 
In the fatal infe ction, amphotericin B treatment was begun two 
days after admission, when amebae had been seen in the CSF. Amphoter-
-1 icin B, 0.25 mg.kg in one daily dose over three to four hours IV 
increasing over a week to 1 mg.kg- 1 , was administered till the patient 
died on the sixteenth day after admi ssion. Sulphadiaz i ne, 160 mg IV 
every six hours was also given. On the s eventh day after admi ssion, 
650 amebae.mm- 3 were seen in the CSF, but many appeared to be dead. The 
-3 
concentration of amphotericin Bin the CSF was 0.184/'g.cm . On the 
eleventh day after admission, the CSF contai ned no amebae and the 
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amphoteri cin B concentration was O. 224/< g . cm . Al though the d iagnosis 
i n this case was made relatively ear l y and treatment with amphotericin 
B started promptly the patient died after being tr eated for thirteen 
days. 
The second case reported by Apley et a l. (1970) was the brother 
of case one and was admitted to hospita l two days later. On the morning 
of admission he c omplained of headache and in the evening developed a 
sore throat and neck pains. A CSF sample was taken and it was cl ear 
and no amebae were seen. The clinical picture was that of an uppe ~ 
r e spirato ry tract infect ion but in view of case one treatment with 
amphotericin Band sulphadiazine was begun. By the seventh day he was 
symptom-f ree . On the eighth day he again c omplained of sore th r oa t with 
head and neck pains. No amebae were seen in the CSF but some were 
grown a nd appeared similar in morphology to those isolated fr om the CSF 
of case one . By the twelfth day he was afebrile and had no signs of 
meningitis but i n view of growth of amebae from the CSF taken four days 
ear l ier, amphotericin B treatment was started again. 0.25 mg amphot er-
-1 -1 icin B.kg IV dai l y over four hours increasing to 0 . 75 mg.kg after 
four days fo r a total of ten days was given . CSF take n on the twelfth 
and eighteenth days a ppeared norma l and no amebae were grown. The 
patient was discharged, s ymptom-f ree . Ten days l ater a CSF sample was 
taken and again no amebae were grown. 
The th ird case was admitted to hosp ita l s i x days after case one. 
On the morning of admi ss ion he c ompla i ned of sore throat and headache, 
vomiting and abdominal pain. The CSF was normal and no treatment was 
given. On the third day, the temperature had become norma l but the 
h eadache continued and there was slight neck stiffness. No amebae were 
seen in the CSF but in view of slight lymphocytosis treatment was 
-1 
started with sulphadia zine and amphotericin B (0.25 mg.kg daily in 
one dose over four hours IV). On the fourth day signs of drug toxicity 
were noted and treatment was stopped. On the eighth day, growth of 
amebae from case two was reported and although the patient was well, 
-1 -1 daily amphotericin B, 0.25 mg.kg increasing to 0.75 mg.kg was given 
IV for ten days. CSF specimens on the 8th, 14th and 24th days were 
normal. No amebae were isolated at any time from this case. He was 
qischarged on the fourteenth day, symptom-free (Apley et al., 1970). 
Apley et al. (1970) do not believe that isolation of amebae from 
the CSF of case two was due to laboratory cross-infection "but case 
three must be considered to have been only doubtfully infected with 
amebae. 11 Griffin (1976), has d isputed the diagnosis of Naegleria 
meningo-encephaliti s i n cases one and two . He contends that an 
Acanthamoeba was involved and that sulphadiazine, rather than ampho-
tericin B, which was given on admission, was responsible for the 
prolonged survival in the f i rst case and survival in the second . 
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The two cases reported by Pan and Ghosh ( 1971) were similarly 
inconclusive i n the nature of the etiological agent involved and the 
effective agent in treatment. Their report deals with two Indian 
children, aged six months and three years, with CNS infections of slow 
onset (3-5 months). CSF sampl e s s howed " mo til e amebae with thin ps eud-
opods ". No strains were isolated and both patients survived . They were 
treated with amphotericin B, sulphadiazine and intrathecal steroids . 
Anderson and Jamieson (1972) reported the case of a fourteen 
year ol d boy from Queensland who had typical acute symptoms and was 
already in the fourth day of illness and comatose by the time amphoter -
icin B treatment was begun . The diagnosis was confirmed by finding 
12,000 white cells . mm- 3 and numerous amebae in the CSF; the amebae 
were cultured and shown to be N. fowleri. Amphotericin B was given in 
-1 
a dose of 1 mg . kg per day IV and penicillin, ampici ll in and sulphadia -
zi ne, he had been having for three days previously, were continued. 
Within two days he became afebr i l e and was talking rationally. After 
-3 fiv e days the CSF white cell count h a d fallen t o 15.mm but many 
atypical amebae were still present. Amphote r ic in B wa s therefore given 
IT and later !Ve nt in small do ses (0.1 mg o n alterna t e day s) and the 
fluid gradually cleared. He was disc harged from ho sp i tal without any 
n eu rological deficit. Thi s case represents the first surviva l where 
t here is definite proof that~- fowleri was involved and survival c an 
be attributed to amphoteric i n B. 
Seidel et al. (pers. comm., 1978) report a more recent case in 
Torrance, California. The patient, a nine year old female, presented 
with typical symptoms of meningo-encephalitis three days before ad-
mission to hospital. Lumbar puncture revealed a purulent CSF and 
motile amebae were seen. Amphotericin B (1 mg.kg- 1 ), sulphadiazine 
. -1 -1 5 (50 mg.kg ), chloramphenicol (25 mg.kg ) and penicillin G (3.4 x 10 
units) were all administered IV immediately on admission. 1.5 mg 
amphotericin B was also given IT. 
The patient was then transferred to Harbour General Hospital 
and was in a coma on admission but responsive to pain and tactile 
stimulation. On arrival the treatment outlined in Table III was 
inst i tuted. 
Table III: Treatment Protocol Used in a Case of PAM 
(Seidel et al., pers. comm., 19 78 ) 
DRUG ROUTE DOSAGE 
Amphoterici n B IV 1.5 -1 day + bid x 3 days mg .kg per 
• 
-1 day qd X 6 days 1.0 mg .kg pe r 
Amphoterici n B IT 1.5 mg per day X 2 days • 1mg QOD 
X 8 days 
Miconazole IV 350 - 2 day..:... tid x 9 days mg . m per 
Miconazole IT 10 mg X 2 days • 10 mg QOD x 8 days 
Rifampi n Ora l 10 mg .kg -1 per day tid x 9 days 
bid = twice da i ly 
tid = three times daily 
qd = every day 
QOD = every other day 
Sulphadiazine (4 g per day IV) was continued for three days 
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until studies confirmed the diagnosis of Naegleria meningo-encephalitis. 
Penicillin and chloramphenicol were continued f or three days until 
bacterial CSF cultures were negative. Decadron (dexamethasone) and 
Dilantin (diphenylhydantoin) were given for increased intracranial 
pressure and sei zure activity, respectively. 
The patient stabilized clinically over the first 48 hours. 
Gradually over the next month of hospitalization her mental status 
improved. No significant neurological deficits were noted at discharge. 
In a few of the other cases of PAM, where proof that N. fowleri 
was the etiological agent involved and amphotericin B given at effec-
tive doses the course of the disease was often too advanced to see 
any effect (Van Den Driessche et al., 1973; Cursons et al., 1976, pers. 
comm. 1979). 
Callicott et al. (1968), isolated an ameba identified as A. 
astronyxis from a spinal fluid sample from a patient with a purulent 
meningitis that remitted spontaneously . The authors were unable to 
provi de evidence that the organism caused the illness and was not just 
a cultural contaminant . 
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Kenney (1971), reported the case of a patient hospitalized for 
acute gastritis of unknown origin . Complement fixation tests revealed 
no antibodies to Entamoeba histolytica but did reveal antibodies to~-
culbertsoni . Over the next two months a rising titer to A. culbertsoni 
antigen was reported . Clinical investigation by a physician did not 
reveal any symptomatology suggestive of cerebromeningeal involvement. 
The patient refused a s pinal tap . 
The gastro-intestina l symptoms continued and a stool examinat ion 
revealed amebae which were called Iodamoeba butschlii. Because of the 
titre to Acanthamoeba antigen, the patient wa s put on anti a mebic th e rapy 
consisting o f Dehydro-Emetine (IM) and ch loroquin e . Complement f ixa tion 
tests two months later demonstrated that the serum titer had decreased. 
This case appears to demonstrate a form of disease between the symptom-
less carrier state an d fulminating meningo-encephalitis which may be 
found to b e more common than at present beli eved. 
The only human Acanthamoeba infections positively diagnosed 
during li fe under circumstances where chemotherapy cou ld have been 
tried were those in the eye . Nagington e t a l. (1 974) repeatedly iso -
lat ed Acanth amoeba from t wo En g l ish patients with corneal ulcers. 
Warhus t a nd Thomas (1975) identified the amebae as~- castellanii a nd 
~- polyphaga. One of the infections was in a 32 year old woman who 
had a mi ld unil ateral keratoconjunctivitis and uveitis which did not 
r e spond to t reatment which included chloramphenicol, idoxuridine, 
3-fluorothymidine, gentamicin, methici llin and later on sulphadiazine 
(500 mg, six hourly). Six months after treatment, because of corneal 
ulceration, pain and loss of vision, a corneal graft was performed but 
the graft was rejected. The other infection described was in a 59 
year old farmer with an identical clinical condition which required 
enucleation of the eye after one year. Treatment in this case included 
chloramphenicol, acetylcysteine, 3-fluorothymidine and clotrimazole eye 
drops. 
Jones et al. (1975) cultiva ted~- polyphaga from corneal ulcers 
of two patients in Houston, Texas. They reported suppression of the 
amebae with paromomycin. Griffin (1978) reported seeing similar material 
at the Armed Forces Institute of Pathology, Washington D.O. and it seems 
likely that Acanthamoeba in the eye will not prove to be strikingly 
rare or unusual. 
